Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThe Mounjaro KwikPen 2.5mg is a pre-filled, once-weekly subcutaneous injection. Each pen contains four doses, and the 2.5mg strength is the starting point for all adults beginning tirzepatide treatment — not a therapeutic target in itself, but a four-week period to let your body adjust. Before your first injection, there are a handful of practical decisions to make: where on your body to inject, how to prepare the site, and what to do if the process feels daunting. This page walks through each of them. Because Mounjaro is a prescription-only medicine, your prescriber and the Patient Information Leaflet (PIL) that comes with your pen are the authoritative guides — what follows is educational context, not a substitute for either.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The three licensed injection sites for the Mounjaro KwikPen are the abdomen (at least a few centimetres away from the navel), the outer thigh, and the upper arm. Practically, most people find the abdomen easiest for self-injection because the skin is pinchable and easy to see. The outer thigh is a solid alternative if your abdomen feels tender in the first week or two.
Rotation is not optional, it is the thing that prevents lumpy, thickened skin building up at a single spot. A good system is to divide whichever area you are using into a mental grid and move to a new square each week. If you inject into the abdomen, avoid the strip of skin directly around your navel and any area where there is a scar. Your prescriber or the PIL can show you an illustrated guide.
One question our prescribers hear regularly is whether the upper arm is really manageable for self-injection. With practice, yes (many people angle the pen in with the opposite hand) but it is harder at first. Start with the abdomen or thigh until you feel confident, then branch out. There is no clinical reason to prefer one site over another in terms of how much the 2.5mg dose the body absorbs.
If you feel apprehensive about giving yourself an injection for the first time, that is entirely normal. A lot of people do. The pen is designed to make the process as straightforward as possible, the needle is covered, it locks after use, and you do not need to dial a dose. Once you have done it a couple of times, most people find it takes less than a minute.
Before you start: wash your hands, take the pen out of the fridge and let it reach room temperature for around 30 minutes (check your PIL for the exact window). Inspect the liquid through the viewing window, it should be clear and colourless or very slightly yellow; if it is cloudy, discoloured, or contains visible particles, do not use that dose. Clean the injection site with an alcohol swab and let it dry before pressing the pen to your skin.
The NHS page on tirzepatide covers the injection technique and common preparation steps clearly. Your PIL goes further with diagrams. If anything looks wrong with the pen or the solution, contact our aftercare team or your prescriber rather than proceeding.
There is sometimes confusion here. The 2.5mg KwikPen is not a lower-efficacy version of Mounjaro, it is the entry point that every person on tirzepatide begins at, regardless of how much weight they want to lose. Its purpose is to reduce the chance of nausea, vomiting, and other gastrointestinal effects that can be more pronounced when the dose starts too high. Think of it as your system finding its footing.
After four weeks at 2.5mg, the typical schedule progresses to the 5mg pen, then upwards in further monthly steps if that is what your prescriber recommends. Some people find the 2.5mg week passes with very little in the way of side effects; others feel nausea particularly after the first injection, which tends to ease. If you are considering whether staying at 2.5mg for longer than four weeks might suit your circumstances, the evidence on an extended 2.5mg period is worth reading, though the decision rests with your prescriber, not a protocol.
Missing an injection matters less than some people fear, but timing does. The general guidance (detailed in your PIL) is that if fewer than four days have passed since your missed dose day, take it as soon as you remember and keep your usual weekly day going forward. Beyond four days, skip that dose and wait for your next scheduled day. Never double up. Your prescriber is the right person to call if you are uncertain about a more advanced dose schedule or a missed injection at any stage.
The Mounjaro KwikPen locks automatically after your injection and must be disposed of in a sharps container, not in household rubbish or recycling. Your local pharmacy or GP surgery can tell you where to deposit full sharps bins in your area.
Mounjaro is a prescription medicine prescribed alongside a reduced-calorie diet and increased physical activity, not instead of them. The clinical trials that established its evidence base (including SURMOUNT-1, published in the New England Journal of Medicine) included structured lifestyle support for all participants. The injection does the pharmacological work; the lifestyle element meaningfully shapes the outcome.
If you are thinking about what treatment might look like for you and want to understand the full options, a look at the treatment overview is a good starting point before speaking with a prescriber. Everything to do with your specific dose, your titration timing, and how your body is responding is a conversation for our clinical team, and if you are already on tirzepatide and moving through the schedule, reading about the 10mg KwikPen can help you know what to expect when you get there. Speak to our prescribers is the easiest way to start.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.